BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 30575685)

  • 1. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urokinase and consumption of α
    Longstaff C; Locke M
    J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo.
    Draxler DF; Zahra S; Goncalves I; Tran H; Hanafi G; Ho H; Keragala CB; Ilich A; Key NS; Myles PS; Medcalf RL
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):172-179. PubMed ID: 33443933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.
    Miszta A; Ahmadzia HK; Luban NLC; Li S; Guo D; Holle LA; Berger JS; James AH; Gobburu JVS; van den Anker J; de Laat B; Wolberg AS
    J Thromb Haemost; 2021 Jan; 19(1):221-232. PubMed ID: 33001565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
    Barrett CD; Moore HB; Vigneshwar N; Dhara S; Chandler J; Chapman MP; Sauaia A; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2020 Dec; 89(6):991-998. PubMed ID: 33230046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis.
    Raska A; Kálmán K; Egri B; Csikós P; Beinrohr L; Szabó L; Tenekedjiev K; Nikolova N; Longstaff C; Roberts I; Kolev K; Wohner N
    J Thromb Haemost; 2024 Mar; 22(3):794-804. PubMed ID: 38016517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
    Godier A; Parmar K; Manandhar K; Hunt BJ
    J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice.
    Hijazi N; Abu Fanne R; Abramovitch R; Yarovoi S; Higazi M; Abdeen S; Basheer M; Maraga E; Cines DB; Higazi AA
    Blood; 2015 Apr; 125(16):2558-67. PubMed ID: 25673638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
    Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
    Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
    J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
    Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
    EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-fibrinolytic agent tranexamic acid suppresses the endotoxin-induced expression of Tnfα and Il1α genes in a plasmin-independent manner.
    Kacer D; Machnitzky E; Fung A; Greene A; Carter D; Rappold J; Prudovsky I
    Transfusion; 2023 May; 63 Suppl 3():S168-S176. PubMed ID: 37070378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation.
    Zhou ZF; Zhai W; Yu LN; Sun K; Sun LH; Xing XF; Yan M
    BMC Anesthesiol; 2021 Feb; 21(1):33. PubMed ID: 33530942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin.
    Silverstein RL; Harpel PC; Nachman RL
    J Biol Chem; 1986 Jul; 261(21):9959-65. PubMed ID: 2942536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin.
    Barrett CD; Moore HB; Banerjee A; Silliman CC; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1053-1061. PubMed ID: 28837538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia.
    Ilich A; Gernsheimer TB; Triulzi DJ; Herren H; Brown SP; Holle LA; Lucas AT; de Laat B; El Kassar N; Wolberg AS; May S; Key NS
    Blood Adv; 2023 Mar; 7(6):900-908. PubMed ID: 36044391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tranexamic acid administration on acute traumatic coagulopathy in rats with polytrauma and hemorrhage.
    Wu X; Benov A; Darlington DN; Keesee JD; Liu B; Cap AP
    PLoS One; 2019; 14(10):e0223406. PubMed ID: 31581265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.